Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
University of Vermont · Stanford Medicine · +2 more institutions
Abstract
Prevalence data from 245 articles involving 2,699,627 persons were used with a hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040. Subgroup analyses were performed for age, gender, presence of metabolic syndrome, region, and smoking status. Sensitivity analysis was conducted for clinical setting and study quality.
The forecasted 2040 prevalence was 55.7%, a three-fold increase since 1990 and a 43.2% increase from the 2020 prevalence of 38.9%. The estimated average yearly increase since 2020 was 2.16%. For those aged
Citation impact
- FWCI
- 39.02
- Percentile
- 100%
- References
- 44
Authors
7- MHMichael H. LeCorresponding
University of Vermont, Stanford Medicine, Stanford University
- YHYee Hui Yeo
Cedars-Sinai Medical Center, Stanford Medicine, Stanford University
- BZBiyao Zou
Stanford Medicine, Stanford University
- SDScott D. Barnet
Stanford Medicine, Stanford University
- LHLinda Henry
Stanford Medicine, Stanford University
Topics & keywords
- Nonalcoholic fatty liver disease
- Bayesian probability
- Internal medicine
- Fatty liver
- Nonalcoholic steatohepatitis
- Medicine
- Liver disease
- Gastroenterology
- Good health and well-being